No Detail Found!

The Impact of Genetic Polymorphisms of Cytochrome P450 (CYP1A1&2D6) Gene in the Incidence of Acute Myeloid Leukaemia

Author(s)
NADA ABDALFATAH DIAB Faculty of Medical Laboratory Sciences, Al Neelain University, Sudan; Faculty of Medical Laboratory Sciences, University Of Khartoum, Sudan.
ABOZER Y. ELDERDERY Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Saudi Arabia; Faculty of Medical Laboratory Sciences, University of El Imam El Mahdi, Sudan
JEREMY MILLS School of Pharmacy and Biomedical Sciences, University of Portsmouth, UK
DAWELBIET A. YAHIA Faculty of Medicine, University of El Imam El Mahdi, Sudan
AlSADIG GASSOUM National Center for Neurological Sciences (NCNS), Khatoum, Sudan
SAWSAN AHMED AL-DEAF National Center for Neurological Sciences (NCNS),,Sudan
ASHRAF ABDELFATAH DEYAB College of Medicine, Majmaah University,KSA,
ENTESAR M TEBIEN Faculty of Medical Laboratory Sciences, Al Neelain University, Sudan ;Faculty of Applied Medical Sciences, Clinical Laboratory Sciences, Shaqra University, Saudi Arabia
HADEIL M.E. IDRIS Faculty of Medical Laboratory Sciences, Al Neelain University, Sudan ;Faculty of Applied Medical Sciences, Clinical Laboratory Sciences, Shaqra University, Saudi Arabia
HIBA B KHALIL Faculty of Medical Laboratory Sciences, Al Neelain University,,Sudan
Abstract
Background: A combination of risk factors effecting of genetic susceptibility and environmental exposure may explain the multi-step process of carcinogenesis/leukemogenesis of acute myeloid leukemia (AML). Objectives: The study objective is to evaluate the role of genetic polymorphisms of human cytochrome P450, namely CYP1A1 & CYP2D6 enzymes, involved in the transformation of chemical and cellular metabolism of drugs and carcinogenic agents as risk factors for AML Sudanese patients. Methods/design: A case control study was conducted between June 2016and June 2018 at the Radiation and Isotope Center Khartoum (RIKA), Sudan. A total of 265 blood specimens (200AML patients and 65 controls) were investigated for allele frequency and genotypes of CYP1A1*2C and CYP2D6*4. The DNA was extracted from all blood specimens, using Qiagen DNA extraction kit. Standard polymerase chain reaction and Restriction fragment length polymorphism analysis (PCR -RFLP) methods were used for genotyping. Results: Although no significant variations were evident for CYP1A1 AG genotype, the GG genotype showed significant differences. We also found no difference in frequencies of alleles A and G of gene CYP1A1 between patients. While, there is evidence of increased frequency when compared with control G allele. The genotype of the CYP2D6*4 allele revealed no significant differences between IM (heterozygous) and the mutant homozygous (PM) genotype. The PM allele for the CYP 2D6 gene was high in both patients and controls. Conclusions: Our findings illustrate that the genetic polymorphisms for xenobiotic metabolizing enzymes CYP1A1 heterozygous AG reveal no significant association with AML, where homozygous GG shows a protective effect. CYP2D6 suggests no association with the risk of AML for both heterozygous IM and the mutant homozygous PM.
Publication Details
Page(s) 899-904
DOI DOI not available
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 14, Issue: 3, Year: 2020

Request the full text from PASTIC

Keywords
CYP1A1, cytochrome P450, CYP 2D6 and AML
0

Citations

0

Downloads

70

Views